Thank you, Madam Chair.
I find both chapter 8 and chapter 10 very interesting, and I thank the Auditor General for bringing them to the committee. Coming from Manitoba, I'm very sensitive to some of the problems with Health Canada's contracts among first nations. As you know, the Virginia Fontaine Addictions Foundation is a lingering sore spot that went on for years and years and years. I think I'll wait to ask my questions on the first nations non-insured benefits, though.
From a regulatory point of view, one of the most valuable things Health Canada does is its regulatory role for safety, etc. I do see that the budget line went up for product reviews as it pertains to drugs. I'm curious, though. Under hazardous substances, and hazardous substances in the workplace, was there a similar bump in the budget for the product review of those things?